Abstract
Diabetes mellitus, a complex and heterogeneous disease associated with hyperglycemia, is a leading cause of mortality and reduces life expectancy. Vanadium complexes have been studied for the treatment of diabetes. The effect of complex [VO(bpy)(mal)]·H2O (complex A) was evaluated in a human hepatocarcinoma (HepG2) cell line and in streptozotocin (STZ)-induced diabetic male Wistar rats conditioned in seven groups with different treatments (n = 10 animals per group). Electron paramagnetic resonance and 51V NMR analyses of complex A in high-glucose Dulbecco’s Modified Eagle Medium (DMEM) revealed the oxidation and hydrolysis of the oxidovanadium(IV) complex over a period of 24 h at 37 °C to give low-nuclearity vanadates “V1” (H2VO4−), “V2” (H2V2O72−), and “V4” (V4O124−). In HepG2 cells, complex A exhibited low cytotoxic effects at concentrations 2.5 to 7.5 μmol L−1 (IC50 10.53 μmol L−1) and increased glucose uptake (2-NBDG) up to 93%, an effect similar to insulin. In STZ-induced diabetic rats, complex A at 10 and 30 mg kg−1 administered by oral gavage for 12 days did not affect the animals, suggesting low toxicity or metabolic impairment during the experimental period. Compared to insulin treatment alone, complex A (30 mg kg−1) in association with insulin was found to improve glycemia (30.6 ± 6.3 mmol L−1 vs. 21.1 ± 8.6 mmol L−1, respectively; p = 0.002), resulting in approximately 30% additional reduction in glycemia. The insulin-enhancing effect of complex A was associated with low toxicity and was achieved via oral administration, suggesting the potential of complex A as a promising candidate for the adjuvant treatment of diabetes.
Similar content being viewed by others
References
ADA (2022) Standards of medical care. J Clin Appl Res Educ 45:1–270
Álvarez-Almazán S, Filisola-Villaseñor JG, Alemán-González-Duhart D et al (2020) Current molecular aspects in the development and treatment of diabetes. J Physiol Biochem 76:13–35. https://doi.org/10.1007/s13105-019-00717-0
Baptistella GB, Manica GCM, de Souza SW et al (2021) An oxalate-bridged oxidovanadium(IV) binuclear complex that improves the in vitro cell uptake of a fluorescent glucose analog. Polyhedron 198:115071. https://doi.org/10.1016/j.poly.2021.115071
Bernardis LL (1970) Prediction of carcass fat, water and lean body mass from Lee’s “nutritive ratio” in rats with hypothalamic obesity. Experientia 26:789–790. https://doi.org/10.1007/BF02232553
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820. https://doi.org/10.1038/414813a
Cam MC, Brownsey RW, McNeill JH (2000) Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent? Can J Physiol Pharmacol 78:829–847. https://doi.org/10.1139/y00-053
Chen C, Bai FY, Zhang R et al (2013) Synthesis, structure, and catalytic bromination of supramolecular oxovanadium complexes containing oxalate. J Coord Chem 66:671–688. https://doi.org/10.1080/00958972.2013.765561
Chen CY, Chen ML, Bin CH et al (2014) α-Hydroxy coordination of mononuclear vanadyl citrate, malate and S-citramalate with N-heterocycle ligand, implying a new protonation pathway of iron-vanadium cofactor in nitrogenase. J Inorg Biochem 141:114–120. https://doi.org/10.1016/j.jinorgbio.2014.08.003
Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-0278-5
Costisor O, Brezeanu M, Journaux Y et al (2001) A novel salt formed by mixed-valence vanadium(IV, V) [(VO)2O(bpy)2(C2O4)2] anions and ferromagnetic [Cu2(bpy)4(C2O4)] cations: structure, spectroscopic characterization and magnetic properties. Eur J Inorg Chem 2:1–28
Crans DC, Henry LR, Cardiff G, Posner BI (2019) Developing vanadium as an antidiabetic or anticancer drug: a clinical and historical perspective. Met Ions Life Sci 19:203–230. https://doi.org/10.1515/9783110527872-014
Danne T, Pettus J, Giaccari A et al (2019) Sotagliflozin added to optimized insulin therapy leads to lower rates of clinically relevant hypoglycemic events at any HbA1c at 52 weeks in adults with type 1 diabetes. Diabetes Technol Ther 21:471–477. https://doi.org/10.1089/dia.2019.0157
Diab MA, Hassan B, El-mezayen HA (2018a) Possible therapeutic role of novel vanadium complexes in diabetes mellitus animal models. Sci J Damietta Fac Sci 8:84–92. https://doi.org/10.21608/sjdfs.2018.194811
Diab MA, Shoir AF, Hassan B et al (2018b) Possible therapeutic role of novel vanadium complexes in diabetes mellitus animal models. Am J Res Commun 6(4):10–32
Domingues N, Pelletier J, Ostenson CG, Castro MMCA (2014) Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats. J Inorg Biochem 131:115–122. https://doi.org/10.1016/j.jinorgbio.2013.11.005
Dubyak GR, Kleinzeller A (1980) The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+–K+)ATPase inhibitor. J Biol Chem 255:5306–5312. https://doi.org/10.1016/s0021-9258(19)70787-x
El-Shafey ES, Elsherbiny ES (2020) The role of apoptosis and autophagy in the insulin-enhancing activity of oxovanadium(IV) bipyridine complex in streptozotocin-induced diabetic mice. Biometals. https://doi.org/10.1007/s10534-020-00237-1
Goldfine AB, Simonson DC, Folli F et al (1995) Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311–3320
Gould TD, Dao DT, Kovacsics CE (2009) Mood and anxiety related phenotypes in mice. NeuroMethods 42:1–20. https://doi.org/10.1007/978-1-60761-303-9
Gylling H, Tuominen JA, Koivisto VA, Miettinen TA (2004) Cholesterol metabolism in type 1 diabetes. Diabetes 53:2217–2222. https://doi.org/10.2337/diabetes.53.9.2217
Hwang SL, Chang HW (2012) Natural vanadium-containing Jeju ground water stimulates glucose uptake through the activation of AMP-activated protein kinase in L6 myotubes. Mol Cell Biochem 360:401–409. https://doi.org/10.1007/s11010-011-1062-4
Iannuzzi MM, Rieger PH (1975) Nature of vanadium(IV) in basic aqueous solution. Inorg Chem 14:2895–2899. https://doi.org/10.1021/ic50154a006
IDF (2021) IDF Diabetes Atlas 10th
Iglesias-González T, Sánchez-González C, Montes-Bayón M et al (2012) Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques. Anal Bioanal Chem 402:277–285. https://doi.org/10.1007/s00216-011-5286-7
Jakusch T, Kiss T (2017) In vitro study of the antidiabetic behavior of vanadium compounds. Coord Chem Rev 351:118–126. https://doi.org/10.1016/j.ccr.2017.04.007
Jiang H, Tian A, Jiang J (2016) Intestinal stem cell response to injury: lessons from Drosophila. Cell Molec Life Sci 73(17):3337–3349
Kerru N, Singh-Pillay A, Awolade P, Singh P (2018) Current anti-diabetic agents and their molecular targets: a review. Eur J Med Chem 152:436–488. https://doi.org/10.1016/j.ejmech.2018.04.061
Kongot M, Reddy DS, Singh V et al (2019) Oxidovanadium(IV) and iron(III) complexes with O2N2 donor linkage as plausible antidiabetic candidates: synthesis, structural characterizations, glucose uptake and model biological media studies. Appl Organomet Chem 34:1–12. https://doi.org/10.1002/aoc.5327
Kongot M, Chaudhary R, Pooja MS et al (2021) Oxidovanadium(IV/V) complexes bound with a ONS donor backbone: the search for therapeutic versatility in one class of compounds. Appl Organomet Chem 35:1–16. https://doi.org/10.1002/aoc.6148
Kontaş Aşkar T, Hişmioğullari AA, Büyükleblebici O, Sarikaya HNER (2021) Effect of vanadium(IV) chloride supplementation on appetite-related hormone levels in rats with experimentally induced diabetes. Turk J Vet Anim Sci 45:501–507. https://doi.org/10.3906/vet-2005-1
Krośniak M, Gawlik M, Gryboś R (2009) Effect of vanadium complexes and insulin administered simultaneously for oxidative stress in STZ diabetic rats. Bull Vet Inst Pulawy 53:535–540
Lima LMA, Belian MF, Silva WE et al (2021) Vanadium(IV)-diamine complex with hypoglycemic activity and a reduction in testicular atrophy. J Inorg Biochem 216:111312. https://doi.org/10.1016/j.jinorgbio.2020.111312
Lyonnet B, Martz F, Martin E (1899) De l’emploi thérapeutique des dérivés du vanadium: vanadate de soude. Assoc typogr, Lyon
Macrae CF, Sovago I, Cottrell SJ, Galek PT, McCabe P et al (2020) J Appl Crystallogr 53:226–235
Marshall MW, Smith BP, Munson AW, Lahmanhn RP (1969) Prediction of carcass fat from body measurements made on live rats differing in age, sex and strain. Br J Nutr 23:353–369. https://doi.org/10.1079/bjn19690042
Mbatha B, Khathi A, Sibiya N et al (2020) Cardio-protective effects of a dioxidovanadium(V) complex in male sprague–dawley rats with streptozotocin-induced diabetes. Biometals. https://doi.org/10.1007/s10534-020-00270-0
Meotti FC, Luiz AP, Pizzolatti MG, Santos ARS (2006) Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the l-arginine-nitric oxide and protein kinase C pathways. J Pharmacol Exp Ther 316:789–796. https://doi.org/10.1124/jpet.105.092825.few
Meyerovitch J, Farfel Z, Sack J, Shechter Y (1987) Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 262:6658–6662. https://doi.org/10.1016/s0021-9258(18)48292-0
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Nakajima K, Yamauchi K, Shigematsu S et al (2000) Selective attenuation of metabolic branch of insulin receptor down- signaling by high glucose in a hepatoma cell line, HepG2 cells. J Biol Chem 275:20880–20886. https://doi.org/10.1074/jbc.M905410199
Novelli ELB, Diniz YS, Galhardi CM et al (2007) Anthropometrical parameters and markers of obesity in rats. Lab Anim 41:111–119. https://doi.org/10.1258/002367707779399518
Patel R, Shervington A, Pariente JA et al (2004) Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus. Ann N Y Acad Sci 1084:71–88. https://doi.org/10.1196/annals.1372.038
Postal K, Santana FS, Hughes DL et al (2021) Stability in solution and chemoprotection by octadecavanadates(IV/V) in E coli cultures. J Inorg Biochem. https://doi.org/10.1016/j.jinorgbio.2021.111438
Poucheret P, Gross R, Cadène A et al (1995) Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studies. Mol Cell Biochem 153:197–204. https://doi.org/10.1007/BF01075938
Punitha ISR, Rajendran K, Shirwaikar A, Shirwaikar A (2005) Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. Evid-Based Complement Altern Med 2:375–381. https://doi.org/10.1093/ecam/neh099
Rehder D, Polenova T, Bühl M (2007) Vanadium-51 NMR. Annu Rep NMR Spectrosc 62:49–114. https://doi.org/10.1016/S0066-4103(07)62002-X
Sakurai H, Fujii K, Watanabe H, Tamura H (1995) Orally active and long-term acting insulin-mimetic vanadyl complex: bis(picolinato)oxovanadium(IV). Biochem Biophys Res Commun 214:1095–1101. https://doi.org/10.1006/bbrc.1995.2398
Sakurai H, Sano H, Takino T, Yasui H (2000) An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats. J Inorg Biochem 80:99–105. https://doi.org/10.1016/S0162-0134(00)00045-3
Samart N, Arhouma Z, Kumar S et al (2018) Decavanadate inhibits mycobacterial growth more potently than other oxovanadates. Front Chem 6:1–16. https://doi.org/10.3389/fchem.2018.00519
Santiago RM, Barbieiro J, Lima MMS et al (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson’s disease are predominantly associated with serotonin and dopamine. Prog Neuro-Psychopharmacol Biol Psychiatry 34:1104–1114. https://doi.org/10.1016/j.pnpbp.2010.06.004
Sarmiento-Ortega VE, Moroni-González D, Díaz A et al (2021) Sodium metavanadate treatment improves glycogen levels in multiple tissues in a model of metabolic syndrome caused by chronic cadmium exposure in Wistar rats. Biometals 34:245–258. https://doi.org/10.1007/s10534-020-00276-8
Ścibior A, Pietrzyk Ł, Plewa Z, Skiba A (2020) Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends. J Trace Elem Med Biol 61:126508. https://doi.org/10.1016/j.jtemb.2020.126508
Skyler JS, Bakris GL, Bonifacio E et al (2017) Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 66:241–255. https://doi.org/10.2337/db16-0806
Smith TS, LoBrutto R, Pecoraro VL (2002) Paramagnetic spectroscopy of vanadyl complexes and its applications to biological systems. Coord Chem Rev 228:1–18. https://doi.org/10.1016/S0010-8545(01)00437-4
Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125:451–472
Stoll S, Schweiger A (2006) EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J Magn Reson 178:42–55. https://doi.org/10.1016/j.jmr.2005.08.013
Tardif A, Julien N, Chiasson JL, Coderre L (2003) Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation. Am J Physiol. https://doi.org/10.1152/ajpendo.00134.2002
Tekus E, Miko A, Furedi N et al (2018) Body fat of rats of different age groups and nutritional states: assessment by micro-CT and skinfold thickness. J Appl Physiol 124:268–275. https://doi.org/10.1152/japplphysiol.00884.2016
Thompson KH, Lichter J, LeBel C et al (2009) Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 103:554–558. https://doi.org/10.1016/j.jinorgbio.2008.12.003
Thulé PM, Liu JM (2000) Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther 7:1744–1752. https://doi.org/10.1038/sj.gt.3301297
Treviño S, Diaz A (2020) Vanadium and insulin: partners in metabolic regulation. J Inorg Biochem. https://doi.org/10.1016/j.jinorgbio.2020.111094
Turtoi M, Anghelache M, Patrascu AA et al (2021) Synthesis, characterization, and in vitro insulin-mimetic activity evaluation of valine schiff base coordination compounds of oxidovanadium(V). Biomedicines. https://doi.org/10.3390/biomedicines9050562
Willsky GR, Goldfine AB, Kostyniak PJ et al (2001) Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). J Inorg Biochem 85:33–42. https://doi.org/10.1016/S0162-0134(00)00226-9
Willsky GR, Chi LH, Liang Y et al (2006) Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate. Physiol Genomics 26:192–201. https://doi.org/10.1152/physiolgenomics.00196.2005
Xie M, Li L, Da YX et al (2010) A new insulin-enhancing agent: [N, N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity. Eur J Med Chem 45:2327–2335. https://doi.org/10.1016/j.ejmech.2010.02.010
Xulu N, Ngubane P, Khathi A et al (2020) Heamanetic effects of a dioxidovanadium(V) complex in STZ-induced diabetic male sprague dawley rats. Diabetes Metab Syndr Obes 14:4321–4333. https://doi.org/10.2147/DMSO.S214726
Zhao Q, Chen D, Liu P et al (2015) Oxidovanadium(IV) sulfate-induced glucose uptake in HepG2 cells through IR/Akt pathway and hydroxyl radicals. J Inorg Biochem 149:39–44. https://doi.org/10.1016/j.jinorgbio.2015.05.005
Zou C, Wang Y, Shen Z (2005) 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods 64:207–215. https://doi.org/10.1016/j.jbbm.2005.08.001
Acknowledgments
The authors thank Fundação Araucária, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Programa Institucional de Internacionalização da CAPES (CAPES – PrInt) and Universidade Federal do Paraná (UFPR) for research grants and scholarships (Finance Code 001). LAMAQ/UTFPR for the ICP-OES analyses, and Ma. Francielly Souza Santana (Laboratório Multiusuário de Raios X de Monocristal, UFPR) for the single-crystal analysis of complex A.
Funding
The work is academic, funded by government agencies with no private resources. This work was financially supported by Fundação Araucária (Project Number 20171010), Conselho Nacional de Desenvolvimento Científico e Tecnológico (Project Number 405105/2021-5) and the Universidade Federal do Paraná (UFPR).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Chemical synthesis and structural analysis of the compound RCRB, JMM and GGN; Animal experiments TPDN, SWS, CHAJ and JMC; HepG2 cells experiments TPN, GCMM, SWS, GV. The first draft of the manuscript was written by GCMM, GP and FGMR and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this article.
Ethical approval
This study was conducted in accordance with ethical guidelines for animal experimental manipulation. All protocols were approved by the Institutional Committee for the Ethical Use of Animals (CEUA/BIO-UFPR; authorization # 1266 B). Efforts were made to minimize the number of animals used and their suffering.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
de Nigro, T.P., Manica, G.C.M., de Souza, S.W. et al. Heteroleptic oxidovanadium(IV)-malate complex improves glucose uptake in HepG2 and enhances insulin action in streptozotocin-induced diabetic rats. Biometals 35, 903–919 (2022). https://doi.org/10.1007/s10534-022-00413-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-022-00413-5